Skip to content

Yoga as therapeutic intervention in women with breast cancer during chemotherapy

Yoga as therapeutic intervention in women with breast cancer during chemotherapy - IKoS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00010810
Enrollment
120
Registered
2016-07-12
Start date
2011-03-18
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer C50

Interventions

Group 1: regenerative Iyengar Yoga, group setting (4-8 individuals), 12 weeks, 60 minutes per week, participants received a written instruction for a homebased-training twice a week for 20-minutes Gro

Sponsors

Klinikum rechts der Isar der TU München
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Women with stage I-III breast cancer undergoing cytotoxic (neo)adjuvant or endocrine adjuvant therapy at the moment of intervention - signed informed consent

Exclusion criteria

Exclusion criteria: In case of acute febrile or psychiatric diseases, patients were excluded from the study. Also women who had experiences in practicing yoga were not included.

Design outcomes

Primary

MeasureTime frame
Inner correspondence (Measurement with a questionnaire at intervention start, in the middle and after the intervention period)

Secondary

MeasureTime frame
Quality of life (EORTC C-30), life satisfaction (Brief Multidimensional Life Satisfaction Scale), fatigue (Cancer Fatigue Scale) and mindfulness (Freiburger Achtsamkeits-Inventar), spiritual attitudes and coping with illness (Spiritual/Religious Attitudes and Coping with Illness questionnaire); measurement with questionnaire at intervention start, after the intervention period and three months after the end of intervention

Countries

Germany

Contacts

Public ContactArndt Büssing

Professur für Lebensqualität, Spiritualität und CopingUniversität Witten / Herdecke

arndt.buessing@uni-wh.de02330-62 3246

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026